Literature DB >> 217003

O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus.

P G Rothberg, T J Harris, A Nomoto, E Wimmer.   

Abstract

Virion RNA of poliovirus type 1 has been analyzed for the linkage between genome-protein VPg and the polyribonucleotide chain. Hydrolysis of the linkage with acid or alkali and enzymatic degradation lead to the conclusion that the bond is neither a phosphodiester such as nucleotidyl-(P-O)-serine (or threonine) nor a phosphoramidate such as nucleotidyl-(P-N)-amino acid. VPg-RNA can be iodinated by the Bolton and Hunter reagent [iodinated 3-(4-hydroxyphenyl)propionic acid N-hydroxysuccinimide ester] but not by the chloramine-T or lactoperoxidase procedures, an observation suggesting that VPg does not contain accessible tyrosine. However, VPg can be labeled with [3H]tyrosine in vivo. Hydrolysis of VPg-[32P]pUp with 5.6 M HCl at 110 degrees yielded 32P-labeled O4-(3'-phospho-5'-uridylyl)tyrosine that could be cleaved with micrococcal nuclease to O4-[32P]phosphotyrosine and uridine 3'-[32P]phosphate. These data establish that VPg is linked to the poliovirus genome by a bond between the O4 of tyrosine and the 5'-P atom of the terminal uridylic acid residue. The 5' end of polio genome RNA can now be described as VPg(Tyr-O)-pU-U-A-A-A-A-C-A-G.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 217003      PMCID: PMC336222          DOI: 10.1073/pnas.75.10.4868

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  TYROSINE-O-PHOSPHATE IN DROSOPHILA.

Authors:  H K MITCHELL; K D LUNAN
Journal:  Arch Biochem Biophys       Date:  1964-07-20       Impact factor: 4.013

2.  THE EXTRACTION OF RIBONUCLEIC ACID FROM POLIOVIRUS BY TREATMENT WITH SODIUM DODECYL SULFATE.

Authors:  B MANDEL
Journal:  Virology       Date:  1964-03       Impact factor: 3.616

3.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

4.  The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded.

Authors:  F Golini; A Nomoto; E Wimmer
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

5.  Esters of phosphoric acid: Phosphoryl hydroxyamino-acids.

Authors:  R H Plimmer
Journal:  Biochem J       Date:  1941-04       Impact factor: 3.857

6.  Encephalomyocarditis virus RNA. III. Presence of a genome-associated protein.

Authors:  D E Hruby; W K Roberts
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

7.  Protein is linked to the 5' end of poliovirus RNA by a phosphodiester linkage to tyrosine.

Authors:  V Ambros; D Baltimore
Journal:  J Biol Chem       Date:  1978-08-10       Impact factor: 5.157

8.  The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg.

Authors:  A Nomoto; N Kitamura; F Golini; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Mechanism of the reaction catalyzed by the DNA untwisting enzyme: attachment of the enzyme to 3'-terminus of the nicked DNA.

Authors:  J J Champoux
Journal:  J Mol Biol       Date:  1978-01-25       Impact factor: 5.469

10.  A high density component in several vertebrate enteroviruses.

Authors:  D J Rowlands; M W Shirley; D V Sangar; F Brown
Journal:  J Gen Virol       Date:  1975-11       Impact factor: 3.891

View more
  87 in total

1.  Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg.

Authors:  A V Paul; E Rieder; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation.

Authors:  E Rieder; A V Paul; D W Kim; J H van Boom; E Wimmer
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  DNA-catalyzed covalent modification of amino acid side chains in tethered and free peptide substrates.

Authors:  On Yi Wong; P I Pradeepkumar; Scott K Silverman
Journal:  Biochemistry       Date:  2011-05-03       Impact factor: 3.162

4.  A convenient sequencing method for 5' protein-linked RNAs.

Authors:  A Nomoto; N Imura
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

5.  DNA-catalyzed serine side chain reactivity and selectivity.

Authors:  Amit Sachdeva; Scott K Silverman
Journal:  Chem Commun (Camb)       Date:  2010-02-25       Impact factor: 6.222

6.  In vitro synthesis of minus-strand RNA by an isolated cereal yellow dwarf virus RNA-dependent RNA polymerase requires VPg and a stem-loop structure at the 3' end of the virus RNA.

Authors:  Toba A M Osman; Robert H A Coutts; Kenneth W Buck
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

7.  Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families.

Authors:  P Argos; G Kamer; M J Nicklin; E Wimmer
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

8.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: purification and enzymatic analysis of the RNA-dependent RNA polymerase 3D(pol).

Authors:  K Gerber; E Wimmer; A V Paul
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: identification of a cis-replicating element in the coding sequence of 2A(pro).

Authors:  K Gerber; E Wimmer; A V Paul
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.